BVXV Annual Long Term Debt
$21.16 M
-$7.45 M-26.04%
31 December 2022
Summary:
As of February 5, 2025, BVXV annual long term debt is $21.16 million, with the most recent change of -$7.45 million (-26.04%) on December 31, 2022. During the last 3 years, it has fallen by -$16.55 million (-43.89%).BVXV Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly Long Term Debt
$24.22 M
+$1.36 M+5.95%
30 June 2023
Summary:
As of February 5, 2025, BVXV quarterly long term debt is $24.22 million, with the most recent change of +$1.36 million (+5.95%) on June 30, 2023. Over the past year, it has increased by +$7.66 million (+46.27%).BVXV Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.0% | +46.3% |
| 3 y3 years | -43.9% | -35.0% |
| 5 y5 years | - | +327.8% |
BVXV Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -43.9% | -35.8% |
BiondVax Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $24.22 M(+5.9%) |
| Mar 2023 | - | $22.86 M(+8.0%) |
| Dec 2022 | $21.16 M(-26.0%) | $21.16 M(+25.7%) |
| Sept 2022 | - | $16.84 M(+1.7%) |
| June 2022 | - | $16.56 M(-25.6%) |
| Mar 2022 | - | $22.25 M(-22.2%) |
| Dec 2021 | $28.61 M(+1411.1%) | $28.61 M(+1460.1%) |
| Sept 2021 | - | $1.83 M(-1.3%) |
| June 2021 | - | $1.86 M(+3.7%) |
| Mar 2021 | - | $1.79 M(-5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $1.89 M(-95.0%) | $1.89 M(-90.0%) |
| Sept 2020 | - | $19.00 M(-49.0%) |
| June 2020 | - | $37.28 M(+1904.2%) |
| Mar 2020 | - | $1.86 M(-95.1%) |
| Dec 2019 | $37.71 M(+50.5%) | $37.71 M(+14.0%) |
| Sept 2019 | - | $33.09 M(+0.2%) |
| June 2019 | - | $33.03 M(+24.8%) |
| Mar 2019 | - | $26.47 M(+5.7%) |
| Dec 2018 | $25.05 M | $25.05 M(+111.6%) |
| Sept 2018 | - | $11.84 M(+109.1%) |
| June 2018 | - | $5.66 M |
FAQ
- What is BiondVax Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual long term debt year-on-year change?
- What is BiondVax Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly long term debt year-on-year change?
What is BiondVax Pharmaceuticals annual long term debt?
The current annual long term debt of BVXV is $21.16 M
What is the all time high annual long term debt for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual long term debt is $37.71 M
What is BiondVax Pharmaceuticals annual long term debt year-on-year change?
Over the past year, BVXV annual long term debt has changed by -$7.45 M (-26.04%)
What is BiondVax Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of BVXV is $24.22 M
What is the all time high quarterly long term debt for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly long term debt is $37.71 M
What is BiondVax Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, BVXV quarterly long term debt has changed by +$7.66 M (+46.27%)